Trueblood Wealth Management’s Travelers Companies TRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Sell
1,518
-2
-0.1% -$606 0.17% 158
2026
Q1
$443K Buy
1,520
+3
+0.2% +$879 0.17% 159
2025
Q4
$440K Buy
1,517
+3
+0.2% +$844 0.17% 162
2025
Q3
$423K Buy
1,514
+3
+0.2% +$803 0.16% 169
2025
Q2
$404K Sell
1,511
-17
-1% -$4.48K 0.17% 169
2025
Q1
$404K Sell
1,528
-675
-31% -$168K 0.19% 149
2024
Q4
$531K Buy
2,203
+396
+22% +$98.9K 0.26% 127
2024
Q3
$423K Buy
1,807
+41
+2% +$9.04K 0.21% 139
2024
Q2
$359K Buy
1,766
+13
+0.7% +$2.79K 0.2% 141
2024
Q1
$403K Buy
1,753
+61
+4% +$13K 0.23% 123
2023
Q4
$322K Buy
+1,692
New +$293K 0.2% 140

Other funds holding TRV

Trueblood Wealth Management's TRV Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Travelers Companies (TRV) stake by 0.13% in Q2 2026, selling an estimated $606 and leaving 1,518 shares worth $501K. The position accounts for 0.17% of the portfolio, ranked #158.

Trueblood Wealth Management first reported a position in TRV in Q4 2023 and has held it in 11 quarters since. The position peaked at $531K in Q4 2024. 600 funds tracked by Wall St. Rank hold TRV as of Q2 2026.

  • Trueblood Wealth Management held 1,518 shares of Travelers Companies worth $501K as of Q2 2026.
  • Trueblood Wealth Management sold 2 Travelers Companies shares in Q2 2026, an estimated $606.
  • Travelers Companies made up 0.17% of Trueblood Wealth Management's portfolio in Q2 2026, its #158 holding.
  • Trueblood Wealth Management first reported a position in Travelers Companies in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Travelers Companies position peaked at $531K in Q4 2024.
  • 600 funds tracked by Wall St. Rank held Travelers Companies as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.